Hongmei Sun

机构：Jiamusi University · ORCID：0000-0003-1003-2404

发表论文 13 篇 · 总被引 201 次 · h-index 7

代表论文

• A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004) (2024 · Cancer Cell · 被引 66)
• CD44+/CD24− breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties (2012 · Clinical & Translational Oncology · 被引 54)
• Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer (2020 · Bioscience Reports · 被引 28)
• ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma (2020 · Technology in Cancer Research & Treatment · 被引 15)
• Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement (2021 · Vaccine · 被引 12)
• Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study (2021 · BMC Gastroenterology · 被引 10)